These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. Advances in tuberous sclerosis complex research: the October 1, 2003, Child Neurology Society Workshop. Finkelstein R J Child Neurol; 2004 Sep; 19(9):734-5. PubMed ID: 15563021 [No Abstract] [Full Text] [Related]
45. [Mouse model of tuberous sclerosis complex]. Feliciano D; Bordey A Med Sci (Paris); 2011 Mar; 27(3):328-30. PubMed ID: 21447310 [No Abstract] [Full Text] [Related]
46. Genotype-phenotype correlations in tuberous sclerosis. De Vries PJ; Bolton PF J Med Genet; 2000 May; 37(5):E3. PubMed ID: 10807702 [No Abstract] [Full Text] [Related]
47. The mTOR inhibitor revolution rolls on. Northrup H Lancet Oncol; 2014 Dec; 15(13):1418-1419. PubMed ID: 25456358 [No Abstract] [Full Text] [Related]
48. Tuberous sclerosis complex and lymphangioleiomyomatosis: miles to go, promises to keep. Henske E Ann Intern Med; 2011 Jun; 154(12):840-1. PubMed ID: 21690600 [No Abstract] [Full Text] [Related]
49. Tuberous sclerosis complex: a tale of two genes. Nass R; Crino PB Neurology; 2008 Mar; 70(12):904-5. PubMed ID: 18347312 [No Abstract] [Full Text] [Related]
50. Acneiform Lesion: Importance of Detailed Skin Examination. Samanta D Indian J Pediatr; 2016 May; 83(5):485-6. PubMed ID: 26558921 [No Abstract] [Full Text] [Related]
51. 50 Years Ago in The Journal of Pediatrics: Tuberous Sclerosis: From Phenotype to Genotype. Sandoval Karamian AG J Pediatr; 2020 Oct; 225():64. PubMed ID: 32977871 [No Abstract] [Full Text] [Related]
52. TS or not TS? Athappily C; Patani R; Chawda S; Rosser E; de Silva R Pract Neurol; 2013 Aug; 13(4):268-70. PubMed ID: 23487808 [No Abstract] [Full Text] [Related]
53. Mutual information-based feature selection in studying perturbation of dendritic structure caused by TSC2 inactivation. Zhou X; Zhu J; Liu KY; Sabatini BL; Wong ST Neuroinformatics; 2006; 4(1):81-94. PubMed ID: 16595860 [TBL] [Abstract][Full Text] [Related]
55. Early therapy with sirolimus reduces size of a large solid renal mass but not seizure activity in an infant with tuberous sclerosis. Hani SB; Artunduaga M; Ludwig K; Bissler JJ; Wolf MTF J Nephrol; 2024 Jan; 37(1):203-205. PubMed ID: 37768546 [No Abstract] [Full Text] [Related]
56. [Tuberous sclerosis complex: is there evidence to establish a genotype-phenotype correlation?]. Ibáñez Micó S; Domingo Jiménez R; Guillén Navarro E; Casas Fernández C An Pediatr (Barc); 2011 Jun; 74(6):421-3. PubMed ID: 21411386 [No Abstract] [Full Text] [Related]
57. New therapies for tuber-less sclerosis: white matter matters? Ess KC; Roach ES Neurology; 2012 Feb; 78(8):520-1. PubMed ID: 22262747 [No Abstract] [Full Text] [Related]
58. Tuberous sclerosis presenting as psychosis in an adolescent patient. Ghosh S; Chaudhury PK; Bhattacharya A; Praharaj SK J Neuropsychiatry Clin Neurosci; 2014; 26(1):E38. PubMed ID: 24515706 [No Abstract] [Full Text] [Related]
60. Phenotypes of the tuberous sclerosis complex with a revision of diagnostic criteria. Gomez MR Ann N Y Acad Sci; 1991; 615():1-7. PubMed ID: 2039135 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]